These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET. Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443 [TBL] [Abstract][Full Text] [Related]
32. Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518 [TBL] [Abstract][Full Text] [Related]
33. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045 [TBL] [Abstract][Full Text] [Related]
34. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Zhang Y; Simpson-Durand CD; Standifer KM Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365 [TBL] [Abstract][Full Text] [Related]
35. PET quantification of brain O-GlcNAcase with [ Lee JH; Liow JS; Paul S; Morse CL; Haskali MB; Manly L; Shcherbinin S; Ruble JC; Kant N; Collins EC; Nuthall HN; Zanotti-Fregonara P; Zoghbi SS; Pike VW; Innis RB EJNMMI Res; 2020 Mar; 10(1):20. PubMed ID: 32172476 [TBL] [Abstract][Full Text] [Related]
36. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility. Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529 [TBL] [Abstract][Full Text] [Related]
37. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490 [TBL] [Abstract][Full Text] [Related]
38. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone. Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029 [TBL] [Abstract][Full Text] [Related]
39. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells. Liao YY; Lee CW; Ho IK; Chiou LC Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115 [TBL] [Abstract][Full Text] [Related]
40. First in-human PET study and kinetic evaluation of [ Bhatt S; Nabulsi NB; Li S; Cai Z; Matuskey D; Bini J; Najafzadeh S; Kapinos M; Ropchan JR; Carson RE; Cosgrove KP; Huang Y; Hillmer AT J Cereb Blood Flow Metab; 2020 Apr; 40(4):695-704. PubMed ID: 30895878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]